Home / Germany / STADA Arzneimittel Aktiengesellschaft
STADA Arzneimittel Aktiengesellschaft
Short position disclosed on March 30, 2015.
0.54% of the capital sold short
1 disclosing funds
140 disclosures on record
DE0007251803 ISIN code
Evolution of the disclosed total
0%0.2%0.4%0.6%
Oct 2025Jan 2026Apr 2026Jul 2026
November 1, 2012 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Swiss & Global Asset Management AG | 0.54% | unchanged | March 30, 2015 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| April 10, 2014 | Marshall Wace LLP | 0.57% | still open |
| April 3, 2014 | Egerton Capital (UK) LLP | 0.28% | still open |
| April 1, 2014 | Egerton Capital (UK) LLP | 0.55% | still open |
| March 28, 2014 | Marshall Wace LLP | 0.45% | still open |
| March 27, 2014 | Egerton Capital (UK) LLP | 0.73% | still open |
| March 26, 2014 | Egerton Capital (UK) LLP | 0.52% | still open |
| March 26, 2014 | Marshall Wace LLP | 0.52% | still open |
| December 3, 2013 | AQR Capital Management, LLC | 0.45% | still open |
| November 5, 2013 | AQR Capital Management, LLC | 0.56% | still open |
| October 2, 2013 | AQR Capital Management, LLC | 0.67% | still open |
| September 16, 2013 | AQR Capital Management, LLC | 0.79% | still open |
| September 4, 2013 | AQR Capital Management, LLC | 0.89% | still open |
| August 21, 2013 | AQR Capital Management, LLC | 0.98% | still open |
| June 19, 2013 | AQR Capital Management, LLC | 1.02% | still open |
| May 16, 2013 | AQR Capital Management, LLC | 0.99% | still open |
| May 8, 2013 | Adelphi Capital LLP | 0.00% | still open |
| May 7, 2013 | Adelphi Capital LLP | 0.22% | still open |
| April 16, 2013 | AQR Capital Management, LLC | 1.05% | still open |
| March 26, 2013 | Adelphi Capital LLP | 0.50% | still open |
| March 15, 2013 | AQR Capital Management, LLC | 1.11% | still open |
| February 11, 2013 | AQR Capital Management, LLC | 1.02% | still open |
| January 24, 2013 | Adelphi Capital LLP | 0.72% | still open |
| January 23, 2013 | AKO Capital LLP | 0.20% | still open |
| January 22, 2013 | AKO Capital LLP | 0.55% | still open |
| January 18, 2013 | AQR Capital Management, LLC | 0.93% | still open |
| January 18, 2013 | Adelphi Capital LLP | 0.83% | still open |
| January 17, 2013 | Adelphi Capital LLP | 0.97% | still open |
| January 10, 2013 | AKO Capital LLP | 0.67% | still open |
| January 9, 2013 | AKO Capital LLP | 0.90% | still open |
| January 8, 2013 | AKO Capital LLP | 1.02% | still open |
| January 7, 2013 | AKO Capital LLP | 1.20% | still open |
| January 4, 2013 | AKO Capital LLP | 1.34% | still open |
| December 17, 2012 | Adelphi Capital LLP | 1.02% | still open |
| December 10, 2012 | AQR Capital Management, LLC | 0.81% | still open |
| December 3, 2012 | Adelphi Capital LLP | 0.94% | still open |
| November 28, 2012 | AQR Capital Management, LLC | 0.70% | still open |
| November 7, 2012 | AQR Capital Management, LLC | 0.61% | still open |
| November 2, 2012 | AKO Capital LLP | 1.44% | still open |
| November 2, 2012 | AQR Capital Management, LLC | 0.58% | still open |
| November 1, 2012 | Adelphi Capital LLP | 0.89% | still open |
Other companies sold short in Germany
- TUI AG 9.00% of the capital sold short
- AUTO1 Group SE 7.29% of the capital sold short
- HelloFresh SE 7.00% of the capital sold short
- Gerresheimer AG 6.46% of the capital sold short
- Hugo Boss AG 6.18% of the capital sold short
- Cancom SE 5.46% of the capital sold short
- PVA TePla AG 5.30% of the capital sold short
- Zalando SE 5.23% of the capital sold short
- LANXESS Aktiengesellschaft 5.11% of the capital sold short
- TAG Immobilien AG 4.99% of the capital sold short
- Tamboran Resources Corp. 4.96% of the capital sold short
- Kontron AG 4.94% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, STADA Arzneimittel Aktiengesellschaft, source Bundesanzeiger, data as at March 30, 2015, https://www.quivad.com/action/stada-arzneimittel-aktiengesellschaft?page=3